Researchers use quality treatment to recover harmed optic nerve filaments Kumar Jeetendra | November 5, 2020 Scientists have used gene therapy to regenerate damaged nerve fibers from the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the main causes of blindness worldwide. Axons – nerve pathways – in the adult central nervous system (CNS) do not normally regenerate after injury and disease, meaning …
Researchers grow first biohybrid fake retina with silk fibroin and retinal cells Kumar Jeetendra | December 13, 2020 An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina constructed with silk fibroin and retinal cells. The biohybrid retina is a cell therapy for the reconstruction of the damaged retina by …
New information shows empowering results for patients with neuro-degenerative blinding eye illness Kumar Jeetendra | December 16, 2020 New data published in the Journal Science Translational Medicine shows encouraging results in a worldwide clinical trial for patients diagnosed with the neuro-degenerative blinding eye disease; Leber Hereditary Optic Neuropathy (LHON. The disease is an inherited type of vision loss estimated to affect 1 in 30,000 to 50,000 individuals. LHON most often afflicts individuals with …
Individuals with vision impedance have higher risk of all-cause mortality Kumar Jeetendra | March 6, 2021 The global population is aging, and so are their eyes. In fact, the number of individuals with vision impairment and blindness is expected to more than double over the next 30 years. A meta-analysis in The Lancet Global Health, comprising 48,000 individuals from 17 studies, found that those with more severe vision impairment had a …
